Interventions for reducing hepatitis C infection in people who inject drugs26 September 2017The first global review to quantify the impact of needle syringe programmes (NSP) and opioid substitution treatment (OST) in reducing the risk of becoming infected with the hepatitis C virus is published in Cochrane Library Drug and Alcohol Review Group and the journal Addiction. The study, has implications for millions of people who are 'at risk' from infection.
How are antimicrobials used around the world in food-producing animals?4 September 2017A new study led by academics at the Bristol Veterinary School has reviewed the literature on the use of antimicrobials (AM) in livestock practice together with the views of stakeholders. The study found that although there are some barriers to change, there is a clear awareness of the issue among the livestock sectors and a willingness to modify AM use.
WUN Strategic Research Workshop1 August 2017The World Universities Network Global Africa Group launched its inaugural Strategic Research Workshop, hosted by the University of Ghana in a two-day event that brought together over sixty researchers from twelve WUN partner universities and ten other universities from four continents.
Transforming UK Translation commitments27 July 2017The Academy of Medical Sciences, Royal Academy of Engineering, Royal Society, and the Wellcome Trust, have outlined a series of commitments to ensure that translation is recognised and celebrated as an integral part of academic research.
How can diagnostics deliver a more effective use of antibiotics in animals?12 July 2017Are there better ways to diagnose animals in need of antibiotics on livestock farms? How will farmers and veterinarians use novel diagnostics in the fight against animal disease? These are some questions a consortium of seven academics – including two veterinarians from the University of Bristol's School of Veterinary Sciences - will address thanks to a £1.75 million grant to understand how better diagnostics can encourage responsible antibiotic use in animals.
New trial for prosthetic hip joint infection28 June 2017The first ever randomised trial to investigate why some patients develop infections after their hip or knee replacement surgery, and which type of surgical revision treatment is best is being run by the University of Bristol and members of the public are being asked to consider taking part.
Preventing progression in diabetic kidney disease13 June 2017Glitazones are drugs used to treat type 2 diabetes because they improve insulin resistance and reduce progression of associated kidney disease. But how do they work? The EBI’s Clinical Primer scheme for early-career clinicians has allowed a Bristol-based clinician, Dr Caroline Platt, to explore this question.
Novel targeting of disease causing cells could transform treatment of autoimmune diseases24 May 2017There is a problem with the traditional treatment of autoimmune and inflammatory conditions. Steroid therapy doesn’t always work, and immunosuppressant drugs can have toxic side effects. Bristol researchers, with the help of an award from the Elizabeth Blackwell Institute, are working to overcome this using novel ways of targeting disease causing cells.
Achievements of the Chronic Kidney Disease HIT in 2016-1723 May 2017One in ten people live with chronic kidney disease (CKD). This is a long-term condition that can increase the risk of heart disease or a sudden deterioration in kidney function, also known as acute kidney injury. The Chronic Kidney Disease Health Integration Team (CKD HIT) is a team of clinical staff and patients, working together to improve patient outcomes and care pathways for patients with kidney disease.
Bristol Bones and Joints highlights for 2016-1723 May 2017The Bones and Joints HIT covers three disease areas: osteoarthritis, osteoporosis and inflammatory rheumatological disorders, underpinned by three themes of patient self-management, patient and public involvement and information technology.
Bristol Immunisation Group’s highlights for 2016-1723 May 2017The Bristol Immunisation Group brings public health, clinical and academic experts together to improve the local performance and resilience of the national immunisation programmes. We also work to develop and deliver improvements through innovation and research.
Successes of the Sexual Health Improvement for Population and Patients HIT in 2016-17 23 May 2017The Sexual Health Improvement for Population and Patients Health Integration Team (SHIPP HIT) works to promote evidence based sexual health improvement. Our focus of the last 12 months has been to support the commissioning of a new integrated sexual health service across Bristol, North Somerset and South Gloucestershire (BNSSG). We have provided commissioners with cost effective evidence based advice that has underpinned the procurement process. In November 2016 the contract to provide the new service was awarded to Unity Sexual Health, a coalition involving Bristol Sexual Health Centre, the specialist service provided by University Hospitals Bristol NHS Foundation Trust, and all major third sector providers.
Respiratory Infection HIT round up for 2016-1723 May 2017Respiratory tract infections place considerable pressure on health care services. Children play a major role in spreading these infections. However, parents often don’t have the information to know when and how best to access health services for common illnesses. A vicious cycle is created of increasing patient demand, higher antibiotic use and a reduction in antibiotic effectiveness.
NIHR i4i Award10 May 2017The aim of this research is to establish whether the AmBeR system can be used to improve the management of children with rare but potentially devastating Urea Cycle Defects. Working with colleagues at UWE and an industry partner Breath Dx, we will trial this entirely novel device to assess its utility as a near to patient ammonia measuring device in collaboration with clinical services in Bristol, Great Ormond St, Guy's Hospital and Birmingham Children's Hospital.
Antibiotics not effective for clinically infected eczema in children23 March 2017Estimates suggest that 40 per cent of eczema flares are treated with topical antibiotics, but findings from a study involving academics from the University of Bristol’s Centre for Academic Primary Care, suggest there is no meaningful benefit from the use of either oral or topical antibiotics for milder clinically infected eczema in children.
New EBI Director from 1 August 201717 March 2017following an open, internal, competitive appointment process, Professor Rachael Gooberman-Hill has been appointed to the role of Director of Elizabeth Blackwell Institute, which she will commence on 1 August 2017.
Early career training and support9 March 2017The Faculties of Biomedical Sciences and Health Sciences have a dynamic postgraduate community enrolled in taught or research-based programmes. Postgrads receive their training in internationally renowned research groups which span the biomedical science disciplines of Biochemistry, Cellular and Molecular Medicine and Physiology, Pharmacology and Neuroscience through to the disciplines associated with population health which include life course epidemiology, genomics, primary care and public health with a particular emphasis on methodology.
Lassoing from the mouth to the heart8 March 2017Infective endocarditis occurs when bacteria cause unwanted blood clots to form on heart valves. Untreated it is fatal; even treated mortality rates are ~ 30%. There are over 2,000 cases diagnosed in the UK annually, and cases are rising.
£7.5M boost for Health Research8 March 2017The Elizabeth Blackwell Institute (EBI) has been awarded the Wellcome Trust’s Institutional Strategic Support Fund (ISSF), designed to support biomedical research and related activities in the UK over the next five years. The ISSF award of £3.75M is being matched by the University. It is the third and largest ISSF award for the EBI and recognises the successful work the Institute has delivered during the previous five years.
Online forecast maps warns sheep farmers about risk of Nematodirosis in lambs1 March 2017With spring fast approaching the parasite Nematodirus is a deadly threat to the lives of lambing flocks. An online risk forecast could help UK sheep farmers assess the risk of outbreaks of the parasite in their lambs and take action before it is too late. The forecast maps will be updated daily to track changes in risk throughout the spring and early summer and include treatment and management advice.